189 related articles for article (PubMed ID: 19438755)
1. High-grade serous carcinoma arising in a low-grade serous carcinoma and micropapillary serous borderline tumour of the ovary in a 23-year-old woman.
Quddus MR; Rashid LB; Hansen K; Sung CJ; Lawrence WD
Histopathology; 2009 May; 54(6):771-3. PubMed ID: 19438755
[No Abstract] [Full Text] [Related]
2. High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.
O'Neill CJ; McBride HA; Connolly LE; Deavers MT; Malpica A; McCluggage WG
Histopathology; 2007 May; 50(6):773-9. PubMed ID: 17493241
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
[TBL] [Abstract][Full Text] [Related]
4. Fallopian tube precursors of ovarian low- and high-grade serous neoplasms.
Vang R; Shih IeM; Kurman RJ
Histopathology; 2013 Jan; 62(1):44-58. PubMed ID: 23240669
[TBL] [Abstract][Full Text] [Related]
5. Microinvasion links ovarian serous borderline tumor and grade 1 invasive carcinoma.
Hogg R; Scurry J; Kim SN; Friedlander M; Hacker N
Gynecol Oncol; 2007 Jul; 106(1):44-51. PubMed ID: 17467045
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
[TBL] [Abstract][Full Text] [Related]
7. [Serous micropapillary invasive carcinoma. Case report on both ovaries].
Espinosa de los Monteros Franco VA; Padilla Rodríguez AL
Ginecol Obstet Mex; 2007 Nov; 75(11):682-6. PubMed ID: 18697443
[TBL] [Abstract][Full Text] [Related]
8. Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary.
Kane A; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
Fertil Steril; 2010 Dec; 94(7):2891-4. PubMed ID: 20537629
[TBL] [Abstract][Full Text] [Related]
9. Different proportions of aneusomic cells in ovarian inclusion cysts associated with serous borderline tumours and serous high-grade carcinomas support different pathogenetic pathways.
Körner M; Burckhardt E; Mazzucchelli L
J Pathol; 2005 Sep; 207(1):20-6. PubMed ID: 16021676
[TBL] [Abstract][Full Text] [Related]
10. Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant.
Gershenson DM; Sun CC; Bodurka D; Coleman RL; Lu KH; Sood AK; Deavers M; Malpica AL; Kavanagh JJ
Gynecol Oncol; 2009 Jul; 114(1):48-52. PubMed ID: 19361839
[TBL] [Abstract][Full Text] [Related]
11. Bilateral micropapillary serous carcinoma of the ovary: a case report.
Gupta R; Singh S; Nigam S
Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of normal-sized ovaries associated with primary peritoneal serous carcinoma for possible precursors of ovarian serous carcinoma.
Seidman JD; Wang BG
Gynecol Oncol; 2007 Jul; 106(1):201-6. PubMed ID: 17477958
[TBL] [Abstract][Full Text] [Related]
13. Subdividing ovarian and peritoneal serous carcinoma into moderately differentiated and poorly differentiated does not have biologic validity based on molecular genetic and in vitro drug resistance data.
Vang R; Shih IeM; Salani R; Sugar E; Ayhan A; Kurman RJ
Am J Surg Pathol; 2008 Nov; 32(11):1667-74. PubMed ID: 18769340
[TBL] [Abstract][Full Text] [Related]
14. Serous psammocarcinoma of the ovary and peritoneum: two case reports and review of the literature.
Alanbay I; Dede M; Ustün Y; Karaşahin E; Deveci S; Günhan O; Yenen MC
Arch Gynecol Obstet; 2009 Jun; 279(6):931-6. PubMed ID: 18982336
[TBL] [Abstract][Full Text] [Related]
15. Calcifications in ovary and endometrium and their neoplasms.
Silva EG; Deavers MT; Parlow AF; Gershenson DM; Malpica A
Mod Pathol; 2003 Mar; 16(3):219-22. PubMed ID: 12640101
[TBL] [Abstract][Full Text] [Related]
16. [Long-term follow-up of patients with borderline tumors of the ovaries].
Adam R; Schmidt C; Di Paolo M; Tulusan AH
Gynakol Rundsch; 1990; 30 Suppl 1():48-50. PubMed ID: 2079299
[No Abstract] [Full Text] [Related]
17. Ovarian lymphoma and serous carcinoma of low malignant potential arising in the same ovary. A case report with literature review of 14 primary ovarian lymphomas.
Skodras G; Fields V; Kragel PJ
Arch Pathol Lab Med; 1994 Jun; 118(6):647-50. PubMed ID: 8204013
[TBL] [Abstract][Full Text] [Related]
18. Hobnail-like cells in serous borderline tumor do not represent concomitant incipient clear cell neoplasms.
Ohishi Y; Oda Y; Kurihara S; Kaku T; Yasunaga M; Nishimura I; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Hum Pathol; 2009 Aug; 40(8):1168-75. PubMed ID: 19368953
[TBL] [Abstract][Full Text] [Related]
19. Significance of p53 expression in ovarian tumors and its correlation to the morphological differentiation.
Rajesh NG; Rekha K; Krishna B
Indian J Pathol Microbiol; 2007 Apr; 50(2):284-7. PubMed ID: 17883046
[TBL] [Abstract][Full Text] [Related]
20. Fascin expression in serous tumors of ovary correlates with aggressiveness of malignancy.
Wen YH; Yee H; Goswami S; Shukla PS
Int J Gynecol Pathol; 2009 Mar; 28(2):187-92. PubMed ID: 19188814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
